Hypoxia-inducible factors: Crosstalk between inflammation and metabolism

Seminars in Cell and Developmental Biology

Volumn 23, Issue 4, 2012, Pages 389-394

  Shay, Jessica E S ^a   Celeste Simon, M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

HIF; Hypoxia; Inflammation; Metabolism; Tumor associated macrophages

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA;

CARCINOGENESIS; CHRONIC INFLAMMATION; HYPOXIA; INFLAMMATORY CELL; MACROPHAGE; METABOLISM; METASTASIS; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; STRESS; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84861960811     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.04.004     Document Type: Review

References (62)

1. 2 availability on human cancer. Nature Reviews Cancer 2008, 8(12):967-975.
2. Murdoch C., Muthana M., Lewis C.E. Hypoxia regulates macrophage functions in inflammation. Journal of Immunology 2005, 175(10):6257-6263.
3. Majmundar A.J., Wong W.J., Simon M.C. Hypoxia-inducible factors and the response to hypoxic stress. Molecular Cell 2010, 40(2):294-309.
4. Murdoch C., Giannoudis A., Lewis C.E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004, 104(8):2224-2234.
5. Saleh M., Trinchieri G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nature Reviews Immunology 2011, 11(1):9-20.
6. Solinas G., Germano G., Mantovani A., Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. Journal of Leukocyte Biology 2009, 86(5):1065-1073.
7. O'Connor P.M., Lapointe T.K., Beck P.L., Buret A.G. Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease. Inflammatory Bowel Diseases 2010, 16(8):1411-1420.
8. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(9):4273-4278.
9. Tian H., McKnight S.L., Russell D.W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes and Development 1997, 11(1):72-82.
10. Qing G., Simon M.C. Hypoxia inducible factor-2alpha: a critical mediator of aggressive tumor phenotypes. Current Opinion in Genetics and Development 2009, 19(1):60-66.
11. Cockman M.E., Masson N., Mole D.R., Jaakkola P., Chang G.W., Clifford S.C., et al. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. Journal of Biological Chemistry 2000, 275(33):25733-25741.
12. 2-regulated prolyl hydroxylation. Science 2001, 292(5516):468-472.
13. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399(6733):271-275.
14. Imtiyaz H.Z., Williams E.P., Hickey M.M., Patel S.A., Durham A.C., Yuan L.J., et al. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. Journal of Clinical Investigation 2010, 120(8):2699-2714.
15. Talks K.L., Turley H., Gatter K.C., Maxwell P.H., Pugh C.W., Ratcliffe P.J., et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. American Journal of Pathology 2000, 157(2):411-421.
16. White J.R., Harris R.A., Lee S.R., Craigon M.H., Binley K., Price T., et al. Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics 2004, 83(1):1-8.
17. Semenza G.L. Life with oxygen. Science 2007, 318(5847):62-64.
18. Patel S.A., Simon M.C. Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death and Differentiation 2008, 15(4):628-634.
19. Gordan J.D., Thompson C.B., Simon M.C. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 2007, 12(2):108-113.
20. Semenza G.L. HIF-1: upstream and downstream of cancer metabolism. Current Opinion in Genetics and Development 2010, 20(1):51-56.
21. Metallo C.M., Gameiro P.A., Bell E.L., Mattaini K.R., Yang J., Hiller K., et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2011.
22. Mullen A.R., Wheaton W.W., Jin E.S., Chen P.H., Sullivan L.B., Cheng T., et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2011.
23. Wise D.R., Ward P.S., Shay J.E., Cross J.R., Gruber J.J., Sachdeva U.M., et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(49):19611-19616.
24. Gordan J.D., Bertout J.A., Hu C.J., Diehl J.A., Simon M.C. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 2007, 11(4):335-347.
25. Kaelin W.G. Kidney cancer: now available in a new flavor. Cancer Cell 2008, 14(6):423-424.
26. Gordan J.D., Lal P., Dondeti V.R., Letrero R., Parekh K.N., Oquendo C.E., et al. HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 2008, 14(6):435-446.
27. Mastrogiannaki M., Matak P., Keith B., Simon M.C., Vaulont S., Peyssonnaux C. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. Journal of Clinical Investigation 2009, 119(5):1159-1166.
28. Keith B., Johnson R.S., Simon M.C. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nature Reviews Cancer 2011.
29. Dioum E.M., Chen R., Alexander M.S., Zhang Q., Hogg R.T., Gerard R.D., et al. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 2009, 324(5932):1289-1293.
30. Lim J.H., Lee Y.M., Chun Y.S., Chen J., Kim J.E., Park J.W. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Molecular Cell 2010, 38(6):864-878.
31. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003, 112(5):645-657.
32. Virchow R. Aetologie der neoplastichen Geschwulste/Pathogenie der neoplastischen Geschwulste. Die Krankhaften Geschwulste 1863, 57-101.
33. Vakkila J., Lotze M.T. Inflammation and necrosis promote tumour growth. Nature Reviews Immunology 2004, 4(8):641-648.
34. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357(9255):539-545.
35. Rhodes J.M., Campbell B.J. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends in Molecular Medicine 2002, 8(1):10-16.
36. Danese S., Mantovani A. Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene 2010, 29(23):3313-3323.
37. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48(4):526-535.
38. Bingle L., Brown N.J., Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. Journal of Pathology 2002, 196(3):254-265.
39. Fang H.Y., Hughes R., Murdoch C., Coffelt S.B., Biswas S.K., Harris A.L., et al. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 2009, 114(4):844-859.
40. Leek R.D., Lewis C.E., Whitehouse R., Greenall M., Clarke J., Harris A.L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Research 1996, 56(20):4625-4629.
41. Kang J.C., Chen J.S., Lee C.H., Chang J.J., Shieh Y.S. Intratumoral macrophage counts correlate with tumor progression in colorectal cancer. Journal of Surgical Oncology 2010, 102(3):242-248.
42. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141(1):39-51.
43. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nature Reviews Cancer 2004, 4(1):71-78.
44. Leek R.D., Talks K.L., Pezzella F., Turley H., Campo L., Brown N.S., et al. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Research 2002, 62(5):1326-1329.
45. Jedinak A., Dudhgaonkar S., Sliva D. Activated macrophages induce metastatic behavior of colon cancer cells. Immunobiology 2010, 215(3):242-249.
46. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124(2):263-266.
47. Wiesener M.S., Turley H., Allen W.E., Willam C., Eckardt K.U., Talks K.L., et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 1998, 92(7):2260-2268.
48. Lin E.Y., Nguyen A.V., Russell R.G., Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. Journal of Experimental Medicine 2001, 193(6):727-740.
49. Oguma K., Oshima H., Aoki M., Uchio R., Naka K., Nakamura S., et al. Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO Journal 2008, 27(12):1671-1681.
50. Knupfer H., Preiss R. Serum interleukin-6 levels in colorectal cancer patients - a summary of published results. International Journal of Colorectal Disease 2010, 25(2):135-140.
51. Naldini A., Filippi I., Miglietta D., Moschetta M., Giavazzi R., Carraro F. Interleukin-1beta regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1alpha. European Journal of Cancer 2010, 46(18):3400-3408.
52. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine 1997, 336(15):1066-1071.
53. Peyssonnaux C., Cejudo-Martin P., Doedens A., Zinkernagel A.S., Johnson R.S., Nizet V. Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. Journal of Immunology 2007, 178(12):7516-7519.
54. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet V., et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453(7196):807-811.
55. Kawaguchi T., Veech R.L., Uyeda K. Regulation of energy metabolism in macrophages during hypoxia. Roles of fructose 2,6-bisphosphate and ribose 1,5-bisphosphate. Journal of Biological Chemistry 2001, 276(30):28554-28561.
56. Rodriguez-Prados J.C., Traves P.G., Cuenca J., Rico D., Aragones J., Martin-Sanz P., et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. Journal of Immunology 2010, 185(1):605-614.
57. Takeda N., O'Dea E.L., Doedens A., Kim J.W., Weidemann A., Stockmann C., et al. Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes and Development 2010, 24(5):491-501.
58. Jubb A.M., Turley H., Moeller H.C., Steers G., Han C., Li J.L., et al. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer. British Journal of Cancer 2009, 101(10):1749-1757.
59. Hu C.J., Sataur A., Wang L., Chen H., Simon M.C. The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Molecular Biology of the Cell 2007, 18(11):4528-4542.
60. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., Simon M.C. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Molecular and Cellular Biology 2003, 23(24):9361-9374.
61. Zeisberger S.M., Odermatt B., Marty C., Zehnder-Fjallman A.H., Ballmer-Hofer K., Schwendener R.A Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. British Journal of Cancer 2006, 95(3):272-281.
62. Branco-Price C., Zhang N., Schnelle M., Evans C., Katschinski D.M., Liao D., et al. Endothelial cell HIF-1alpha and HIF-2alpha differentially regulate metastatic success. Cancer Cell 2012, 21(1):52-65.